In May, 2016, the company invested 10million yuan to establish a new company, Chengdu purefa pharmaceutical research and Development Co., Ltd., which is mainly focused on the innovation of traditional Chinese medicine and the internationalization of quality standards of traditional Chinese medicine, serving pharmaceutical enterprises and drug research and development institutions. In addition, after the completion of the project, there will be an increase in the number of gram to kilogram active ingredients of traditional Chinese medicineCustomized R & D and separation and purification will be able to respond quickly and provide GMP and other normative services according to customer requirements.
        The company's featured services are as follows:
      1. Pharmaceutical research on new drugs, including process research, quality standard research (mainly for the establishment and verification of analytical methods), impurity research and stability research;
      2. Pharmaceutical research part of generic drug conformity evaluation, including quality standard comparison study, impurity comparison study, in vitro dissolution study, stability study, etc;
        3. Separate entrustment for impurity research, including impurity separation, identification, comparison, provision of impurity reference materials, etc;
      4. Optimization of production process to reduce impurities, improve yield and reduce costs. The company is mainly responsible for the separation and purification of peptides and natural products for more than 20 years, and has unique advantages in the optimization of product separation and purification process;
      5. Transfer and cooperation of independent R & D projects. After more than 10 years of accumulation, the company has owned manyIndependent intellectual propertyProjects and products.  

Company business license: